Dan M. Roden

97.0k citations

609 papers · 35.6k indexed · 9 hit papers · h-index 95

Impact in

Cardiology and Cardiovascular Medicine top 0.02%
- Cardiac electrophysiology and arrhythmias
- Cardiac Arrhythmias and Treatments
- Cardiac pacing and defibrillation studies
- Atrial Fibrillation Management and Outcomes
- ECG Monitoring and Analysis
Pharmacology top 0.02%
- Pharmacogenetics and Drug Metabolism

Papers in

Cardiology and Cardiovascular Medicine 410
- Cardiac electrophysiology and arrhythmias 337
- Cardiac Arrhythmias and Treatments 95
- Atrial Fibrillation Management and Outcomes 57
- Cardiac pacing and defibrillation studies 49
Pharmacology 71
- Pharmacogenetics and Drug Metabolism 58

Co-authors: Raymond L. Woosley Dawood Darbar Joshua C. Denny Alfred L. George Prince J. Kannankeril G. Wilkinson Mark E. Anderson Richard B. Kim
Journals: Circulation (71 papers)The American Journal of Cardiology (36 papers)Clinical Pharmacology & Therapeutics (34 papers)Heart Rhythm (33 papers)Journal of the American College of Cardiology (23 papers)
Partner nations: United States Germany United Kingdom

In The Last Decade

Dan M. Roden

594 papers receiving 34.5k citations

Hit Papers

9 papers align trajectories log scale

Association of step counts over time with the risk of chronic disease in the All of Us Research Program 2022 · 105 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2022 Nature Medicine
2020 JAMA
2019 The Lancet
2018 The Lancet Oncology
2010 Bioinformatics
2010 Circulation
2006 Circulation
2004 New England Journal of Medicine
1998 Journal of Clinical Investigation

Peers

Countries citing papers authored by Dan M. Roden

Since Specialization

Citations

This map shows the geographic impact of Dan M. Roden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan M. Roden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan M. Roden more than expected).

Fields of papers citing papers by Dan M. Roden

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dan M. Roden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan M. Roden. The network helps show where Dan M. Roden may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Dan M. Roden, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Dan M. Roden Line = papers co-authored together Dan M. Roden links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	PO-05-028 THE TYROSINE KINASE INHIBITOR ENTRECTINIB RESULTS IN VENTRICULAR TACHYCARDIA AND BRUGADA PHENOCOPY THROUGH INHIBITION OF SODIUM CURRENT Heart Rhythm ·Matthew R. Fleming, Tao Yang, John M. Wells, Byung-Kwan Choi, Travis D. Richardson, Eiman Jahangir, Björn C. Knollmann, Dan M. Roden	2025	1
2	ParSE-seq: a calibrated multiplexed assay to facilitate the clinical classification of putative splice-altering variants Nature Communications ·Matthew J. O’Neill, Tao Yang, Julie Laudeman, Franz Miguel Sancho Camarena, Κωνσταντίνος Καραμανλής, Joseph F. Solus, Dan M. Roden, Andrew M. Glazer	2024	3
3	Benchmarking computational variant effect predictors by their ability to infer human traits Genome biology ·Alexander Andreyuk, Da Kuang, Megan Lancaster, Roujia Li, Karen Liu, Jhonatan David Marquina Salas, Atina G. Coté, Yingzhou Wu, Robert A. Hegele, Dan M. Roden, Frederick P. Roth	2024	12
4	Leveraging generative AI to prioritize drug repurposing candidates for Alzheimer’s disease with real-world clinical validation npj Digital Medicine ·Chao Yan, V. P. Lazarchuk, Alyson L. Dickson, Bingshan Li, Zhexing Wen, Dan M. Roden, Christoph Stein, Peter J. Embí, Josh F. Peterson, QiPing Feng, Bradley Malin, Wei‐Qi Wei	2024	29
5	Promise and Peril of a Genotype‐First Approach to Mendelian Cardiovascular Disease Journal of the American Heart Association ·Babken Asatryan, Brittney Murray, Rafik Tadros, Marina Rieder, Ravi A. Shah, Ghaith Sharaf Dabbagh, Andrew P. Landstrom, Stephan Dobner, Patricia B. Munroe, Christopher M. Haggerty, Argelia Medeiros‐Domingo, Anjali Owens, Iftikhar J. Kullo, Christopher Semsarian, Tobias Reichlin, Andreas S. Barth, Dan M. Roden, Cynthia A. James, James S. Ware, C. Anwar A. Chahal, (unknown)	2024	4
6	Veratridine Can Bind to a Site at the Mouth of the Channel Pore at Human Cardiac Sodium Channel NaV1.5 International Journal of Molecular Sciences ·Alican Gulsevin, Andrew M. Glazer, Tiffany Shields, Brett M. Kroncke, Dan M. Roden, Jens Meiler	2022	4
7	Polygenic Risk Score to Identify Subclinical Coronary Heart Disease Risk in Young Adults Circulation Genomic and Precision Medicine ·Quinn S. Wells, Minoo Bagheri, Aaron W. Aday, Deepak K. Gupta, Christian M. Shaffer, Wei‐Qi Wei, E Lunkenheimer, Sadiya S. Khan, Philip Greenland, Thomas J. Wang, C. Michael Stein, Dan M. Roden, Jonathan D. Mosley	2021	14
8	Accelerating Precision Drug Development and Drug Repurposing by Leveraging Human Genetics Assay and Drug Development Technologies ·Jill M. Pulley, Jana K. Shirey-Rice, Robert R. Lavieri, Rebecca N Jerome, Yo KANATANI, David M. Aronoff, Lisa Bastarache, Xinnan Niu, Kenneth J. Holroyd, Dan M. Roden, Eric P. Skaar, Colleen M. Niswender, Lawrence J. Marnett, Craig W. Lindsley, L.B. Ekstrom, А. К. Пиминов, Gordon R. Bernard, Charles C. Hong, Joshua C. Denny	2017	30
9	Phenome-wide scanning identifies multiple diseases and disease severity phenotypes associated with HLA variants Science Translational Medicine ·Jason H. Karnes, Lisa Bastarache, Christian M. Shaffer, Silvana Gaudieri, Yaomin Xu, Andrew M. Glazer, Jonathan D. Mosley, Shilin Zhao, Soumya Raychaudhuri, S. Mallal, Zhan Ye, John Mayer, Murray H. Brilliant, Scott J. Hebbring, Dan M. Roden, Elizabeth J. Phillips, Joshua C. Denny	2017	74
10	Enhancing Literacy in Cardiovascular Genetics: A Scientific Statement From the American Heart Association Circulation Cardiovascular Genetics ·Seema Mital, Kiran Musunuru, Vidu Garg, Mark W. Russell, David E. Lanfear, Rajat Gupta, Kathleen T. Hickey, Michael J. Ackerman, Marco Pérez, Dan M. Roden, Daniel Woo, Caroline S. Fox, Stephanie M. Ware	2016	57
11	Phenome-Wide Association Studies as a Tool to Advance Precision Medicine Annual Review of Genomics and Human Genetics ·Joshua C. Denny, Lisa Bastarache, Dan M. Roden	2016	149
12	Blocking Scn10a Channels in Heart Reduces Late Sodium Current and Is Antiarrhythmic Circulation Research ·Tao Yang, Thomas C. Atack, Dina Myers Stroud, Wei Zhang, Lynn Hall, Dan M. Roden	2012	123
13	Striking In Vivo Phenotype of a Disease-Associated Human SCN5A Mutation Producing Minimal Changes in Vitro Circulation ·Hiroshi Watanabe, Tao Yang, Dina Myers Stroud, J. S. Lowe, Louise Harris, Thomas C. Atack, Dao Wen Wang, Susan B. Hipkens, Brenda F. Leake, Lynn Hall, Sabina Kupershmidt, Nagesh Chopra, Mark A. Magnuson, Naohito Tanabe, Björn C. Knollmann, Alfred L. George, Dan M. Roden	2011	90
14	Informatic and Functional Approaches to Identifying a Regulatory Region for the Cardiac Sodium Channel Circulation Research ·Thomas C. Atack, Dina Myers Stroud, Hiroshi Watanabe, Tao Yang, Lynn Hall, Susan B. Hipkens, J. S. Lowe, Brenda F. Leake, Mark A. Magnuson, Ping Yang, Dan M. Roden	2011	10
15	PheWAS: demonstrating the feasibility of a phenome-wide scan to discover gene–disease associations Bioinformatics ·Joshua C. Denny, Marylyn D. Ritchie, Melissa Basford, Jill M. Pulley, Lisa Bastarache, Kristin Brown‐Gentry, Shun-ichi OTSUKA, Dan Masys, Dan M. Roden, Dana C. Crawford Hit paper breakdown →	2010	703
16	Prevention of Torsade de Pointes in Hospital Settings Circulation ·Barbara J. Drew, Michael J. Ackerman, Marjorie Funk, W. Brian Gibler, Paul Kligfield, Venu Menon, George J. Philippides, Dan M. Roden, Wojciech Zaręba Hit paper breakdown →	2010	606
17	Mutations in Sodium Channel β1- and β2-Subunits Associated With Atrial Fibrillation Circulation Arrhythmia and Electrophysiology ·Hiroshi Watanabe, Dawood Darbar, Daniel W. Kaiser, Kim Jiramongkolchai, Sameer Chopra, Brian S. Donahue, Prince J. Kannankeril, Dan M. Roden	2009	182
18	Abstract 2684: Modulators of Normal ECG Intervals Identified in a large Electronic Medical Record Circulation ·Fengchou Tsai, Jonathan S. Schildcrout, Dan Masys, E.-O. Ruprecht, Jill M. Pulley, Melissa Basford, Dan M. Roden, Joshua C. Denny	2009	1
19	Cardiac Sodium Channel ( SCN5A ) Variants Associated with Atrial Fibrillation Circulation ·Dawood Darbar, Prince J. Kannankeril, Brian S. Donahue, Gayle Kucera, Tanya Stubblefield, Jonathan L. Haines, Alfred L. George, Dan M. Roden	2008	249
20	Metabolic Syndrome and Risk of Development of Atrial Fibrillation Circulation ·Hiroshi Watanabe, Naohito Tanabe, Toru Watanabe, Dawood Darbar, Dan M. Roden, Shigeru Sasaki, Yoshifusa Aizawa	2008	326

About Dan M. Roden

Dan M. Roden is a scholar working on Cardiology and Cardiovascular Medicine, Pharmacology, Molecular Biology, Genetics and Toxicology, having authored 609 papers that have together received 35.6k indexed citations. Recurring topics across this work include Cardiac electrophysiology and arrhythmias (337 papers), Ion channel regulation and function (194 papers), Cardiac Arrhythmias and Treatments (95 papers), Pharmacogenetics and Drug Metabolism (58 papers), Atrial Fibrillation Management and Outcomes (57 papers), Genomics and Rare Diseases (50 papers), Genetic Associations and Epidemiology (50 papers) and Cardiac pacing and defibrillation studies (49 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (21.6k citations), Pharmacology (3.6k citations), Molecular Biology (15.9k citations), Cellular and Molecular Neuroscience (2.5k citations) and Toxicology (433 citations). Dan M. Roden has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Raymond L. Woosley, Dawood Darbar, Joshua C. Denny, Alfred L. George, Prince J. Kannankeril, G. Wilkinson, Mark E. Anderson, Richard B. Kim, Tao Yang and Marylyn D. Ritchie. Their work appears in journals such as Circulation, The American Journal of Cardiology, Clinical Pharmacology & Therapeutics, Heart Rhythm and Journal of the American College of Cardiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact